Le Lézard
Classified in: Health, Covid-19 virus
Subject: SVY

Survey Finds That 77 Percent of People Are Concerned About the Coronavirus Outbreak and 50 Percent Have Changed Hygiene Behaviours


- Increasing hand hygiene and avoiding travel are among actions taken to minimise risk

- Leading hygiene expert Dr Lisa Ackerley calls for continued hygiene awareness and advocates 'destination handwashing' to break the chain of infection

- Health authorities and international experts are the most trusted sources of information

- More fact-based information to debunk myths surrounding the outbreak is needed

SLOUGH, England, Feb. 24, 2020 /PRNewswire/ -- A large portion of the population ? as much as 50% ? say that they have changed one or more behaviours to cope with the threat of COVID-19, including increasing handwashing and sanitising as well as avoiding public places and cutting back on travel. The findings are part of a new multi-national public opinion poll by Harris Interactive and RB, the maker of Dettol and Lysol. 

Global study results of changing hygiene behaviours in response to COVID-19 outbreak

The survey showed that:

54% handwash more often
44% avoid crowds
41% use hand-sanitiser more often
34% wear masks more often
32% stay home more often
31% avoid travel

The vast majority of people (95%) are aware of the virus outbreak, but the levels of concern about the personal risk from infection differ according to geography.  Globally, 66% of respondents said that are worried for their family and their own safety. The survey revealed that countries closer to the epicentre of the virus outbreak, including India, Malaysia and Thailand and China, expressed the highest levels of concern about contracting the virus (92%, 91%, 86% and 84% respectively).  These countries also report the highest levels of personal actions taken to prevent exposure to infection such as handwashing.

British and German respondents appear to be the least concerned about the virus but many still report modifying their behaviours such as handwashing (35% UK, 40% Germany), using hand sanitisers more often (26% UK, 26% Germany) or wearing masks (6% UK, 5% Germany). Globally, the majority of people believe that good hygiene will protect them, especially in the countries with highest levels of COVID-19 infection.

"This survey shows that while concern about the novel coronavirus is high, it is encouraging to see that people are already adapting their hygiene behaviours such as handwashing," said Dr Lisa Ackerley, a Chartered Environmental Health Practitioner and Hygiene Expert.  "Not only will this help to protect against coronavirus infection, but the simple action of hand hygiene at key moments helps guard against other respiratory and gastrointestinal diseases."

The survey found some differences in attitudes and behaviours between gender, with women (57%) more likely than men (51%), to have adopted increased handwashing and hand sanitising behaviours.  Older respondents, those of 65+ years who tend to be most at risk of complications from infections, were less likely to say they had changed their handwashing behaviour.

Dr Ackerley also advocates for the concept of 'destination handwashing' that centres around washing your hands when you arrive at a destination to help prevent the spread of infection.  "When you arrive home, at work, at a restaurant, or at the gym, these are moments to trigger reminders for handwashing," she said.  "Simply keeping your hands away from your face when travelling is also a useful tip to reduce the risk of transferring viruses from dirty hands to the eyes, nose or mouth."

The global spread of the novel strain of coronavirus (named SARS-Cov-2) has led to an epidemic of a different kind; the spreading of inaccurate news about the virus has been called an 'infodemic' by the World Health Organisation.[i] 

With so much information about the global health emergency, there is also an increasing risk of misinformation or the proliferation of myths about how consumers can combat the virus.  There is clear need to make sure that information is accurate and from trusted sources.  The survey showed most people turn to international and local health authorities as their most trusted source of information on COVID-19, followed by international and local news outlets.  

The survey is the latest in a programme of efforts to support the fight against the spread of the virus and to increase knowledge for consumers worldwide.  RB recently announced two major donations; £5.5 million in cash and hygiene products to China through its Dettol brand and additional RMB £550,000 cash donation to support expectant mothers in Hubei Province through its infant nutrition MJN business.

"We encourage good hygiene practices to break the chain of infection at all times, but it is vital to increase awareness during times of increased concern or when new outbreaks such as COVID-19 occur," said Dr Bruce Charlesworth, Chief Medical Officer for RB.

About RB

RB is a leading global health, hygiene and home company inspired by a vision of the world where people are healthier and live better. Its purpose is to make a difference by giving people innovative solutions for healthier lives and happier homes. Through its two business units, Health and Hygiene Home, RB has operations in over 60 countries and its products reach millions of people globally every day. Its trusted household brands include names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick. RB's drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 diverse, talented entrepreneurs worldwide.

For more information visit www.rb.com

The survey was conducted with 11,000 adults across 11 countries:  Australia, China, Germany, India, Japan, Malaysia, Saudi Arabia, South Africa, Thailand, United Kingdom, United States. The online survey with ten questions was fielded from 6-11 February 2020.

References

[i] Novel Coronavirus (2019-nCoV) Situation Report ? 13. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200202-sitrep-13-ncov-v3.pdf Last accessed 17.02.20

Photo - https://mma.prnewswire.com/media/1094018/RB_Coronavirus_Infographic.jpg

 

 

 


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: